INTERNATIONAL BIOTECHNOLOGY TRUST PLC - Q3 2023 holdings

$297 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 65 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
INCY  INCYTE CORP INC COM$20,704,303
-7.2%
358,4540.0%6.98%
+2.7%
VRTX  VERTEX PHARMACEUTICALS IN$7,302,540
-1.1%
21,0000.0%2.46%
+9.4%
ILMN  ILLUMINA INC COM$6,932,640
-26.7%
50,5000.0%2.34%
-19.0%
AXSM  AXSOME THERAPEUTICS INC.$4,071,089
-2.7%
58,3000.0%1.37%
+7.6%
RVNC  REVANCE THERAPEUTICS INC$3,308,800
-54.7%
288,7260.0%1.12%
-49.8%
RCKT  ROCKET PHARMACEUTICALS IN$3,193,320
+3.2%
156,0000.0%1.08%
+14.2%
MDGL  MADRIGAL PHARMACEUTICALS$2,669,421
-36.9%
18,3000.0%0.90%
-30.1%
LEGN  Legend Biotech Corpsponsored ads$2,551,320
-2.7%
38,0000.0%0.86%
+7.5%
JAZZ  JAZZ PHARMACEUTICALS PLC$2,225,164
+4.4%
17,2000.0%0.75%
+15.6%
MIRM  MIRUM PHARMACEUTICALS INC$2,128,950
+22.2%
67,5000.0%0.72%
+35.0%
IONS  IONIS PHARMACEUTICALS INC$1,949,190
+10.5%
43,0000.0%0.66%
+22.3%
ZLAB  ZAI LAB LTD ADRadr$1,917,890
-12.4%
78,9580.0%0.65%
-3.1%
CLDX  CELLDEX THERAPEUTICS INC$1,322,242
-18.9%
48,0990.0%0.44%
-10.3%
CYTK  CYTOKINETICS INC COMMON S$1,090,020
-9.6%
37,0000.0%0.37%0.0%
GH  GUARDANT HEALTH INC COM$1,081,130
-17.2%
36,5000.0%0.36%
-8.3%
INSM  INSMED INC COM PAR $.01$1,012,124
+19.7%
40,1000.0%0.34%
+32.7%
NTLA  INTELLIA THERAPEUTICS INC$757,920
-22.5%
24,0000.0%0.26%
-14.4%
AGIO  AGIOS PHARMACEUTICALS INC$593,520
-12.7%
24,0000.0%0.20%
-3.4%
BEAM  BEAM THERAPEUTICS INC COM$564,705
-24.7%
23,5000.0%0.19%
-16.7%
 VENTYX BIOSCIENCES INC CO$520,650
+6.0%
15,0000.0%0.18%
+16.7%
IMAB  I-MAB SPONSORED ADSsponsored ads$409,859
-55.7%
310,4990.0%0.14%
-51.1%
PTCT  PTC THERAPEUTICS INC COM$380,630
-45.0%
17,0000.0%0.13%
-39.3%
PTGX  PROTAGONIST THERAPEUTICS$331,932
-39.6%
19,9000.0%0.11%
-32.9%
ARVN  ARVINAS INC COM$333,540
-20.8%
17,0000.0%0.11%
-12.5%
RLMD  RELMADA THERAPEUTICS INC$30,000
+21.5%
10,0000.0%0.01%
+25.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GILEAD SCIENCES INC COMMO28Q3 20239.3%
INCYTE CORP INC COM28Q3 20237.9%
BIOMARIN PHARMACEUTICALS INC28Q3 20237.5%
REGENERON PHARMS.27Q3 20239.0%
BIOGEN INC COMMON STOCK26Q3 20238.7%
VERTEX PHARMS.25Q3 20238.4%
AMGEN INC COM25Q3 20237.9%
NEUROCRINE BIOSCIENCES INC25Q3 20236.9%
ALYNYLAM PHARMACEUTICALS INC25Q3 20236.7%
IONIS PHARMS.25Q3 20234.0%

View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.

Latest significant ownerships (13-D/G)
INTERNATIONAL BIOTECHNOLOGY TRUST PLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Altus Pharmaceuticals Inc.February 12, 2009? ?
MICROMET, INC.February 14, 20081,907,3904.7%
EPIMMUNE INCFebruary 15, 20051,279,6598.0%
ESSENTIAL THERAPEUTICS INCApril 29, 20032,500,00011.7%
TARGETED GENETICS CORP /WA/April 18, 2003? ?
ESSENTIAL THERAPEUTICS INCNovember 05, 20011113.0%
ONYX PHARMACEUTICALS INCOctober 15, 20011113.0%
CORVAS INTERNATIONAL INCOctober 12, 20011113.0%
RIBOZYME PHARMACEUTICALS INCOctober 05, 20011113.0%

View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-08
13F-HR2023-05-18
13F-HR2023-02-01
13F-HR2022-11-08
13F-HR2022-08-16
13F-HR2022-05-20
13F-HR2022-02-15
13F-HR2021-11-12
13F-HR2021-08-11

View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.

Compare quarters

Export INTERNATIONAL BIOTECHNOLOGY TRUST PLC's holdings